The Humoral Response of Patients With Cancer to Breakthrough COVID-19 Infection or the Fourth BNT162b2 Vaccine Dose
癌症患者对突破性 COVID-19 感染或第四剂 BNT162b2 疫苗的体液反应
期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyad003
Cohen, Idan; Campisi-Pfinto, Salvatore; Rozenberg, Orit; Colodner, Raul; Bar-Sela, Gil
